Concepedia
Statistics
Publications
24
Citations
1.7K
H-Index
18
Active since
1983
Affiliations
Heidelberg University(Current)
German Cancer Research Center
Research Institute of Radiology
University of Basel
University Hospital Heidelberg
Jochen Schuhmacher is an author at Heidelberg University specializing in medicine, pharmacology, and immunology.
Top concepts
MedicinePharmacologyImmunologyImmunotherapyOncologyRadiologyNuclear MedicineRadiation OncologyPathologyTumor Biology
Publications per year
1983–2007
PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
Marcus Henze, Jochen Schuhmacher, Peter Hipp et al. · PubMed · 2001 · 266 citations
Half-life Alpha, Engineering, Oncologic Imaging +18
Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics
Sergey M Kipriyanov, Gerhard Moldenhauer, Jochen Schuhmacher et al. · Journal of Molecular Biology · 1999 · 194 citations
Oncology, Improved Antigen Binding, Tumor Therapy +10
Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
Marcus Henze, Antonia Dimitrakopoulou‐Strauss, Stefanie Milker-Zabel et al. · PubMed · 2005 · 163 citations
GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog.
Jochen Schuhmacher, Hanwen Zhang, Josef Doll et al. · PubMed · 2005 · 144 citations
A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
Sylvie Froidevaux, Martine Calame‐Christe, Jochen Schuhmacher et al. · PubMed · 2004 · 136 citations
1–5 of 24